Brief: Ascelia Pharma Gets SEK 105 Mln In Rights Issue

Ascelia Pharma AB

06/09/2024 07:43

Sept 6 (Reuters) - Ascelia Pharma AB  ACELP.ST :
    * SAID ON THURSDAY CO INITIALLY GETS ABOUT SEK 105 MILLION
THROUGH
RIGHTS ISSUE
    * FINAL SUMMARY SHOWS THAT 16.5 MLN UNITS, CORRESPONDING TO
ABOUT
80% OF RIGHTS ISSUE, HAVE BEEN SUBSCRIBED FOR BY EXERCISE OF
UNIT RIGHTS
    * IN ADDITION, 4.3 MLN UNITS HAVE BEEN SUBSCRIBED FOR
WITHOUT
EXERCISE OF UNIT RIGHTS, CORRESPONDING TO ABOUT 20% OF RIGHTS
ISSUE
    * RIGHTS ISSUE IS THUS SUBSCRIBED TO TOTAL OF 100%
    * UPON FULL EXERCISE OF ALL ISSUED WARRANTS SERIES TO 1,
ASCELIA
PHARMA MIGHT RECEIVE ADDITIONAL PROCEEDS OF ABOUT SEK 21 – 70
MILLION IN APRIL 2025

        
 Source text for Workspace:  urn:newsml:reuters.com:*:nMFN7KmnH7
 Further company coverage:  ACELP.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))